GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Haisco Pharmaceutical Group Co Ltd (SZSE:002653) » Definitions » PB Ratio

Haisco Pharmaceutical Group Co (SZSE:002653) PB Ratio : 7.74 (As of May. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Haisco Pharmaceutical Group Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-25), Haisco Pharmaceutical Group Co's share price is ¥29.86. Haisco Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.86. Hence, Haisco Pharmaceutical Group Co's PB Ratio of today is 7.74.

The historical rank and industry rank for Haisco Pharmaceutical Group Co's PB Ratio or its related term are showing as below:

SZSE:002653' s PB Ratio Range Over the Past 10 Years
Min: 5.31   Med: 8.06   Max: 18.68
Current: 7.74

During the past 13 years, Haisco Pharmaceutical Group Co's highest PB Ratio was 18.68. The lowest was 5.31. And the median was 8.06.

SZSE:002653's PB Ratio is ranked worse than
85.98% of 1312 companies
in the Biotechnology industry
Industry Median: 2.5 vs SZSE:002653: 7.74

During the past 12 months, Haisco Pharmaceutical Group Co's average Book Value Per Share Growth Rate was 9.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 12.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 6.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Haisco Pharmaceutical Group Co was 56.40% per year. The lowest was -78.50% per year. And the median was 8.10% per year.

Back to Basics: PB Ratio


Haisco Pharmaceutical Group Co PB Ratio Historical Data

The historical data trend for Haisco Pharmaceutical Group Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haisco Pharmaceutical Group Co PB Ratio Chart

Haisco Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.31 6.49 7.73 7.88 6.17

Haisco Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.08 6.62 6.35 6.17 7.04

Competitive Comparison of Haisco Pharmaceutical Group Co's PB Ratio

For the Biotechnology subindustry, Haisco Pharmaceutical Group Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haisco Pharmaceutical Group Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haisco Pharmaceutical Group Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Haisco Pharmaceutical Group Co's PB Ratio falls into.



Haisco Pharmaceutical Group Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Haisco Pharmaceutical Group Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=29.86/3.856
=7.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Haisco Pharmaceutical Group Co  (SZSE:002653) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Haisco Pharmaceutical Group Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Haisco Pharmaceutical Group Co (SZSE:002653) Business Description

Traded in Other Exchanges
N/A
Address
No. 17, Sanxiang Avenue, Shannan District, Tibet Autonomous Region, Zetang, CHN, 856000
Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.
Executives
Fan Xiu Lian Directors, executives
Zheng Wei Directors, executives
Wang Meng Secretary Dong
Wang Jun Min Directors, executives
Deng Xiang Directors, executives
Liu Han Bing Supervisors
Zhang Xiao Xu Supervisors
Tan Hong Executives
Shen Ping Director
Liang Yong Supervisors
Chen Long Independent director
Duan Qing Liang Supervisors

Haisco Pharmaceutical Group Co (SZSE:002653) Headlines

No Headlines